Comments on:

Pharmaceutical industry haunted by support for government health care

Back to the article » By |
Drug makers are under fire as the $84,000 price tag on a new hepatitis medicine has galvanized the debate over prescription drug costs. But the pharmaceutical industry could be mounting a much stronger defense if it weren't haunted by its support for government health care. At the heart of the latest controversy is Sovaldi, a miracle drug introduced this year and manufactured by Gilead...

To learn more about commenting on and our community guidelines, please see our comments FAQ.